GSK Consumer Healthcare Korea Appoints Shin Dong-woo as CEO
[Asia Economy Reporter Lee Gwan-joo] GSK Consumer Healthcare Korea announced on the 2nd that it has appointed Shin Dong-woo as the new CEO and President of its Korean subsidiary.
Shin Dong-woo, the newly appointed CEO and President, is known as an expert who has successfully led the domestic business of various global brands over 28 years in the consumer healthcare and general consumer goods sectors.
From 2020 until recently, he served as the CEO of GSK Consumer Healthcare Hong Kong, successfully completing the integration with Pfizer Consumer Healthcare, and achieved a business turnaround within two years through stable organizational building and management innovation.
From 2015 to 2020, he served as the head of Pfizer Korea Consumer Healthcare division and the Asia-Pacific cluster leader, building a balanced brand portfolio including Centrum and Advil, driving continuous double-digit growth, turning the Korean business profitable, and recording significant achievements. He was also the first appointed head of Sanofi Korea’s Consumer Healthcare division, successfully launching major brands.
In addition to the pharmaceutical consumer goods sector, he gained 14 years of experience in marketing and sales at global consumer goods companies such as Coca-Cola, 20th Century Fox Home Entertainment, and L'Or?al.
As the head of GSK Consumer Healthcare Korea, Shin will continue the growth momentum in the Korean market and lead the spin-off from GSK scheduled for this year, launching the new company.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- No Vaccine or Treatment Available: 139 Dead Already... "The Number Will Rise"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, GSK Consumer Healthcare previously announced in February that its new official company name will be ‘Haleon,’ and it will spin off from GSK around mid-year. Considering product packaging changes and preparation time, the Korean subsidiary will maintain its current corporate name (GSK Consumer Healthcare Korea) for the time being.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
